APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lenalidomide

Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS). For MM it is used after at least one other treatment and generally together with dexamethasone.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS). For MM it is used after at least one other treatment and generally together with dexamethasone.

Selected research

Industry Growth & Trends

Global Lenalidomide Industry Growth and Trends Forecast to 2032

21 December 202579 pages

Choose your research edition.

Industry ResearchLenalidomide Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Lenalidomide Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Lenalidomide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lenalidomide Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lenalidomide Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS). For MM it is used after at least one other treatment and generally together with dexamethasone.

In China, Lenalidomide key players include Celgene, SL Pharma.

In terms of product, 25 mg Capsules is the largest segment, with a share over 40%. And in terms of application, the largest application is Multiple myeloma (MM), followed by Myelodysplastic syndromes (MDS).

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Lenalidomide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lenalidomide market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lenalidomide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lenalidomide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lenalidomide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lenalidomide Market by Company

Celgene

SL Pharma

Lenalidomide Segment by Type

5 mg Capsules

10 mg Capsules

15 mg Capsules

25 mg Capsules

Lenalidomide Segment by Application

Multiple myeloma (MM)

Myelodysplastic syndromes (MDS)

Lenalidomide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lenalidomide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lenalidomide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lenalidomide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lenalidomide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lenalidomide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5 mg Capsules Table 2. Major Company of 10 mg Capsules Table 3. Major Company of 15 mg Capsules Table 4. Major Company of 25 mg Capsules Table 5. Global Lenalidomide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Lenalidomide Sales by Type (2021-2026) & (K Pcs) Table 7. Global Lenalidomide Sales Market Share in Volume by Type (2021-2026) Table 8. Global Lenalidomide Sales by Type (2021-2026) & (US$ Million) Table 9. Global Lenalidomide Sales Market Share in Value by Type (2021-2026) Table 10. Global Lenalidomide Price by Type (2021-2026) & (USD/Pcs) Table 11. Global Lenalidomide Sales by Type (2027-2032) & (K Pcs) Table 12. Global Lenalidomide Sales Market Share in Volume by Type (2027-2032) Table 13. Global Lenalidomide Sales by Type (2027-2032) & (US$ Million) Table 14. Global Lenalidomide Sales Market Share in Value by Type (2027-2032) Table 15. Global Lenalidomide Price by Type (2027-2032) & (USD/Pcs) Table 16. North America Lenalidomide Sales by Type (2021-2026) & (K Pcs) Table 17. North America Lenalidomide Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Lenalidomide Sales by Type (2021-2026) & (K Pcs) Table 19. Europe Lenalidomide Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Lenalidomide Sales by Type (2021-2026) & (K Pcs) Table 21. Asia-Pacific Lenalidomide Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Lenalidomide Sales by Type (2021-2026) & (K Pcs) Table 23. Latin America Lenalidomide Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Lenalidomide Sales by Type (2021-2026) & (K Pcs) Table 25. Middle East and Africa Lenalidomide Sales by Type (2021-2026) & (US$ Million) Table 26. Lenalidomide Industry Trends Table 27. Lenalidomide Industry Drivers Table 28. Lenalidomide Industry Opportunities and Challenges Table 29. Lenalidomide Industry Restraints Table 30. Global Lenalidomide Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Lenalidomide Revenue Market Share by Company (2021-2026) Table 32. Global Lenalidomide Sales by Company (2021-2026) & (K Pcs) Table 33. Global Lenalidomide Sales Share by Company (2021-2026) Table 34. Global Lenalidomide Market Price by Company (2021-2026) & (USD/Pcs) Table 35. Global Lenalidomide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Lenalidomide Major Company Production Sites and Headquarters Table 37. Global Lenalidomide Company, Product Type & Application Table 38. Global Lenalidomide Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Lenalidomide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Lenalidomide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Lenalidomide Sales by Region (2021-2026) & (K Pcs) Table 43. Global Lenalidomide Sales Market Share in Volume by Region (2021-2026) Table 44. Global Lenalidomide Sales by Region (2021-2026) & (US$ Million) Table 45. Global Lenalidomide Sales Market Share in Value by Region (2021-2026) Table 46. Global Lenalidomide Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 47. Global Lenalidomide Sales by Region (2027-2032) & (K Pcs) Table 48. Global Lenalidomide Sales Market Share in Volume by Region (2027-2032) Table 49. Global Lenalidomide Sales by Region (2027-2032) & (US$ Million) Table 50. Global Lenalidomide Sales Market Share in Value by Region (2027-2032) Table 51. Global Lenalidomide Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2027-2032) Table 52. Global Lenalidomide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Lenalidomide Sales by Application (2021-2026) & (K Pcs) Table 54. Global Lenalidomide Sales Market Share in Volume by Application (2021-2026) Table 55. Global Lenalidomide Sales by Application (2021-2026) & (US$ Million) Table 56. Global Lenalidomide Sales Market Share in Value by Application (2021-2026) Table 57. Global Lenalidomide Price by Application (2021-2026) & (USD/Pcs) Table 58. Global Lenalidomide Sales by Application (2027-2032) & (K Pcs) Table 59. Global Lenalidomide Sales Market Share in Volume by Application (2027-2032) Table 60. Global Lenalidomide Sales by Application (2027-2032) & (US$ Million) Table 61. Global Lenalidomide Sales Market Share in Value by Application (2027-2032) Table 62. Global Lenalidomide Price by Application (2027-2032) & (USD/Pcs) Table 63. North America Lenalidomide Sales by Application (2021-2026) & (K Pcs) Table 64. North America Lenalidomide Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Lenalidomide Sales by Application (2021-2026) & (K Pcs) Table 66. Europe Lenalidomide Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Lenalidomide Sales by Application (2021-2026) & (K Pcs) Table 68. Asia-Pacific Lenalidomide Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Lenalidomide Sales by Application (2021-2026) & (K Pcs) Table 70. Latin America Lenalidomide Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Lenalidomide Sales by Application (2021-2026) & (K Pcs) Table 72. Middle East and Africa Lenalidomide Sales by Application (2021-2026) & (US$ Million) Table 73. Celgene Company Information Table 74. Celgene Business Overview Table 75. Celgene Lenalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 76. Celgene Lenalidomide Product Portfolio Table 77. Celgene Recent Development Table 78. SL Pharma Company Information Table 79. SL Pharma Business Overview Table 80. SL Pharma Lenalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 81. SL Pharma Lenalidomide Product Portfolio Table 82. SL Pharma Recent Development Table 83. North America Lenalidomide Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 84. North America Lenalidomide Sales by Country (2021-2026) & (K Pcs) Table 85. North America Lenalidomide Sales Market Share by Country (2021-2026) Table 86. North America Lenalidomide Sales Forecast by Country (2027-2032) & (K Pcs) Table 87. North America Lenalidomide Sales Market Share Forecast by Country (2027-2032) Table 88. North America Lenalidomide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. North America Lenalidomide Market Size by Country (2021-2026) & (US$ Million) Table 90. North America Lenalidomide Market Share by Country (2021-2026) Table 91. North America Lenalidomide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. North America Lenalidomide Market Share Forecast by Country (2027-2032) Table 93. Europe Lenalidomide Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 94. Europe Lenalidomide Sales by Country (2021-2026) & (K Pcs) Table 95. Europe Lenalidomide Sales Market Share by Country (2021-2026) Table 96. Europe Lenalidomide Sales Forecast by Country (2027-2032) & (K Pcs) Table 97. Europe Lenalidomide Sales Market Share Forecast by Country (2027-2032) Table 98. Europe Lenalidomide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Europe Lenalidomide Market Size by Country (2021-2026) & (US$ Million) Table 100. Europe Lenalidomide Market Share by Country (2021-2026) Table 101. Europe Lenalidomide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Europe Lenalidomide Market Share Forecast by Country (2027-2032) Table 103. Asia-Pacific Lenalidomide Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 104. Asia-Pacific Lenalidomide Sales by Country (2021-2026) & (K Pcs) Table 105. Asia-Pacific Lenalidomide Sales Market Share by Country (2021-2026) Table 106. Asia-Pacific Lenalidomide Sales Forecast by Country (2027-2032) & (K Pcs) Table 107. Asia-Pacific Lenalidomide Sales Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Lenalidomide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Lenalidomide Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Lenalidomide Market Share by Country (2021-2026) Table 111. Asia-Pacific Lenalidomide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Lenalidomide Market Share Forecast by Country (2027-2032) Table 113. Latin America Lenalidomide Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 114. Latin America Lenalidomide Sales by Country (2021-2026) & (K Pcs) Table 115. Latin America Lenalidomide Sales Market Share by Country (2021-2026) Table 116. Latin America Lenalidomide Sales Forecast by Country (2027-2032) & (K Pcs) Table 117. Latin America Lenalidomide Sales Market Share Forecast by Country (2027-2032) Table 118. Latin America Lenalidomide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Lenalidomide Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Lenalidomide Market Share by Country (2021-2026) Table 121. Latin America Lenalidomide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Lenalidomide Market Share Forecast by Country (2027-2032) Table 123. Middle East and Africa Lenalidomide Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 124. Middle East and Africa Lenalidomide Sales by Country (2021-2026) & (K Pcs) Table 125. Middle East and Africa Lenalidomide Sales Market Share by Country (2021-2026) Table 126. Middle East and Africa Lenalidomide Sales Forecast by Country (2027-2032) & (K Pcs) Table 127. Middle East and Africa Lenalidomide Sales Market Share Forecast by Country (2027-2032) Table 128. Middle East and Africa Lenalidomide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East and Africa Lenalidomide Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East and Africa Lenalidomide Market Share by Country (2021-2026) Table 131. Middle East and Africa Lenalidomide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Lenalidomide Market Share Forecast by Country (2027-2032) Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Lenalidomide Distributors List Table 136. Lenalidomide Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Lenalidomide Image Figure 2. Global Lenalidomide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lenalidomide Market Size (2021-2032) & (US$ Million) Figure 4. Global Lenalidomide Sales (2021-2032) & (K Pcs) Figure 5. 5 mg Capsules Image Figure 6. Global 5 mg Capsules Sales YoY Growth (2021-2032) & (K Pcs) Figure 7. 10 mg Capsules Image Figure 8. Global 10 mg Capsules Sales YoY Growth (2021-2032) & (K Pcs) Figure 9. 15 mg Capsules Image Figure 10. Global 15 mg Capsules Sales YoY Growth (2021-2032) & (K Pcs) Figure 11. 25 mg Capsules Image Figure 12. Global 25 mg Capsules Sales YoY Growth (2021-2032) & (K Pcs) Figure 13. Global Lenalidomide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Lenalidomide Market Share by Type 2025 VS 2032 Figure 15. North America Lenalidomide Sales Market Share in Volume by Type in 2025 Figure 16. North America Lenalidomide Sales Market Share in Value by Type in 2025 Figure 17. Europe Lenalidomide Sales Market Share in Volume by Type in 2025 Figure 18. Europe Lenalidomide Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Lenalidomide Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Lenalidomide Sales Market Share in Value by Type in 2025 Figure 21. Latin America Lenalidomide Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Lenalidomide Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Lenalidomide Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Lenalidomide Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Lenalidomide Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Multiple myeloma (MM) Image Figure 28. Global Multiple myeloma (MM) Sales YoY Growth (2021-2032) & (K Pcs) Figure 29. Myelodysplastic syndromes (MDS) Image Figure 30. Global Myelodysplastic syndromes (MDS) Sales YoY Growth (2021-2032) & (K Pcs) Figure 31. Global Lenalidomide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Lenalidomide Market Share by Application 2025 VS 2032 Figure 33. North America Lenalidomide Sales Market Share in Volume by Application in 2025 Figure 34. North America Lenalidomide Sales Market Share in Value by Application in 2025 Figure 35. Europe Lenalidomide Sales Market Share in Volume by Application in 2025 Figure 36. Europe Lenalidomide Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Lenalidomide Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Lenalidomide Sales Market Share in Value by Application in 2025 Figure 39. Latin America Lenalidomide Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Lenalidomide Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Lenalidomide Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Lenalidomide Sales Market Share in Value by Application in 2025 Figure 43. North America Lenalidomide Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 44. North America Lenalidomide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Lenalidomide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Lenalidomide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Lenalidomide Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 48. Europe Lenalidomide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Lenalidomide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Lenalidomide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Lenalidomide Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 52. Asia-Pacific Lenalidomide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Lenalidomide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Lenalidomide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Lenalidomide Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 56. Latin America Lenalidomide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Lenalidomide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Lenalidomide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Lenalidomide Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 60. Middle East and Africa Lenalidomide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Lenalidomide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Lenalidomide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Lenalidomide Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Lenalidomide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg Capsules
  • 10 mg Capsules
  • 15 mg Capsules
  • 25 mg Capsules
Applications
  • Multiple myeloma (MM)
  • Myelodysplastic syndromes (MDS)
Companies covered
  • Celgene
  • SL Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lenalidomide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lenalidomide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lenalidomide Market by Type
  6. 1.3.1 5 mg Capsules
  7. 1.3.2 10 mg Capsules
  8. 1.3.3 15 mg Capsules
  9. 1.3.4 25 mg Capsules
  10. 1.4 Global Lenalidomide Market Size by Type
  11. 1.4.1 Global Lenalidomide Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Lenalidomide Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Lenalidomide Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Lenalidomide Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Lenalidomide Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Lenalidomide Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Lenalidomide Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Lenalidomide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lenalidomide Industry Trends
  2. 2.2 Lenalidomide Industry Drivers
  3. 2.3 Lenalidomide Industry Opportunities and Challenges
  4. 2.4 Lenalidomide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lenalidomide Revenue (2021-2026)
  2. 3.2 Global Top Players by Lenalidomide Sales (2021-2026)
  3. 3.3 Global Top Players by Lenalidomide Price (2021-2026)
  4. 3.4 Global Lenalidomide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lenalidomide Major Company Production Sites & Headquarters
  6. 3.6 Global Lenalidomide Company, Product Type & Application
  7. 3.7 Global Lenalidomide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lenalidomide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lenalidomide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lenalidomide Tier 1, Tier 2, and Tier 3
4 Lenalidomide Regional Status and Outlook
  1. 4.1 Global Lenalidomide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lenalidomide Historic Market Size by Region
  3. 4.2.1 Global Lenalidomide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lenalidomide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lenalidomide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lenalidomide Forecasted Market Size by Region
  7. 4.3.1 Global Lenalidomide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lenalidomide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lenalidomide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lenalidomide by Application
  1. 5.1 Lenalidomide Market by Application
  2. 5.1.1 Multiple myeloma (MM)
  3. 5.1.2 Myelodysplastic syndromes (MDS)
  4. 5.2 Global Lenalidomide Market Size by Application
  5. 5.2.1 Global Lenalidomide Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Lenalidomide Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Lenalidomide Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Lenalidomide Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Lenalidomide Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Lenalidomide Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Lenalidomide Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Lenalidomide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Celgene
  2. 6.1.1 Celgene Company Information
  3. 6.1.2 Celgene Business Overview
  4. 6.1.3 Celgene Lenalidomide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Celgene Lenalidomide Product Portfolio
  6. 6.1.5 Celgene Recent Developments
  7. 6.2 SL Pharma
  8. 6.2.1 SL Pharma Company Information
  9. 6.2.2 SL Pharma Business Overview
  10. 6.2.3 SL Pharma Lenalidomide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 SL Pharma Lenalidomide Product Portfolio
  12. 6.2.5 SL Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Lenalidomide Sales by Country
  2. 7.1.1 North America Lenalidomide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lenalidomide Sales by Country (2021-2026)
  4. 7.1.3 North America Lenalidomide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lenalidomide Market Size by Country
  6. 7.2.1 North America Lenalidomide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lenalidomide Market Size by Country (2021-2026)
  8. 7.2.3 North America Lenalidomide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lenalidomide Sales by Country
  2. 8.1.1 Europe Lenalidomide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lenalidomide Sales by Country (2021-2026)
  4. 8.1.3 Europe Lenalidomide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lenalidomide Market Size by Country
  6. 8.2.1 Europe Lenalidomide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lenalidomide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lenalidomide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lenalidomide Sales by Country
  2. 9.1.1 Asia-Pacific Lenalidomide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lenalidomide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lenalidomide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lenalidomide Market Size by Country
  6. 9.2.1 Asia-Pacific Lenalidomide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lenalidomide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lenalidomide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lenalidomide Sales by Country
  2. 10.1.1 South America Lenalidomide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lenalidomide Sales by Country (2021-2026)
  4. 10.1.3 South America Lenalidomide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lenalidomide Market Size by Country
  6. 10.2.1 South America Lenalidomide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lenalidomide Market Size by Country (2021-2026)
  8. 10.2.3 South America Lenalidomide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lenalidomide Sales by Country
  2. 11.1.1 Middle East and Africa Lenalidomide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lenalidomide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lenalidomide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lenalidomide Market Size by Country
  6. 11.2.1 Middle East and Africa Lenalidomide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lenalidomide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lenalidomide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lenalidomide Value Chain Analysis
  2. 12.1.1 Lenalidomide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lenalidomide Production Mode & Process
  7. 12.2 Lenalidomide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lenalidomide Distributors
  10. 12.2.3 Lenalidomide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst